Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > Down almost 3%

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Oct 13, 2022 5:02pm

68 Views

Post# 35023466

RE:RE:RE:Down almost 3%

A graph of the release curve would also help detail data including what the release curve looks like before 8 hours. CZO talked about data at 8 and 12 hours only.

prophetoffactz wrote:
"Disappointing share price action."

Tens-of-thousands of shares were dumped all at once out of CIBC taking the stock down to a low of $.68 on one of the Canadian markets today. The US market closed up today. Four of seven Canadian markets closed at $.70-$.73. The last trade in Canada was at $.70. 128,700 shares traded on all markets in Canada today.

The deal that CZO expects to sign will drive home the value of what CZO discovered. Today's results were not peer-reviewed and there wasn't a full statistical analysis presented such as sample size, and dispersion of the data and a test of statistical significance. CZO has all the data and perhaps it will be published as previous data. A deal will be based on all of the data.